Literature DB >> 11804839

Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.

Dominique Pessayre1, Abdellah Mansouri, Bernard Fromenty.   

Abstract

Rich diet and lack of exercise are causing a surge in the prevalence of obesity and hepatic steatosis, which causes "primary" steatohepatitis in some patients. Ultrastructural mitochondrial lesions, decreased activity of respiratory chain complexes, and impaired ability to synthesize ATP are observed in these patients. Reactive oxygen species (ROS) may increase tumor necrosis factor-alpha (TNF-alpha) production and also oxidize fat deposits. TNF-alpha and lipid peroxidation products impair the flow of electrons along the respiratory chain, causing overreduction of respiratory chain components and enhanced mitochondrial ROS formation. Steatohepatitis can also be due to alcohol, drugs, or other causes that either directly increase ROS formation or first impair respiration, which secondarily increases ROS formation. Higher ROS formation in secondary steatohepatitis could cause more lipid peroxidation, cytokine induction, and fibrogenesis than in primary steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804839     DOI: 10.1152/ajpgi.00426.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  60 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 3.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 4.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

6.  Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis.

Authors:  Mònica Tous; Natàlia Ferré; Jordi Camps; Francesc Riu; Jorge Joven
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

7.  Caspase 1 activation is protective against hepatocyte cell death by up-regulating beclin 1 protein and mitochondrial autophagy in the setting of redox stress.

Authors:  Qian Sun; Wentao Gao; Patricia Loughran; Rick Shapiro; Jie Fan; Timothy R Billiar; Melanie J Scott
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

8.  Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction.

Authors:  Long Wang; Yisong Lv; Huixiang Yao; Li Yin; Jianhui Shang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 9.  Inflammatory mediators of hepatic steatosis.

Authors:  Elizabeth Hijona; Lander Hijona; Juan I Arenas; Luis Bujanda
Journal:  Mediators Inflamm       Date:  2010-03-16       Impact factor: 4.711

10.  Beneficial Effects of Fermented Green Tea Extract in a Rat Model of Non-alcoholic Steatohepatitis.

Authors:  Kazuo Nakamoto; Fusako Takayama; Mitsumasa Mankura; Yuki Hidaka; Toru Egashira; Tetsuya Ogino; Hiromu Kawasaki; Akitane Mori
Journal:  J Clin Biochem Nutr       Date:  2009-04-25       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.